Current Assets: The sum of all assets that are classified as current, because they will provide a benefit within one year.
Ginkgo Bioworks Holdings, Inc. (DNA) had Current Assets of $471.84M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$170.16M |
|
$-312.76M |
|
$46.97M |
|
$123.18M |
|
$485.43M |
|
$-315.28M |
|
$1.68M |
|
$-313.60M |
|
$-297.19M |
|
$-312.76M |
|
$-312.76M |
|
$-312.76M |
|
$-296.31M |
|
$-315.28M |
|
$-259.68M |
|
55.46M |
|
55.46M |
|
$-5.64 |
|
$-5.64 |
|
| Balance Sheet Financials | |
|
Current Assets |
$471.84M |
$167.78M |
|
$647.86M |
|
$1.12B |
|
$95.97M |
|
-- |
|
$515.14M |
|
$611.11M |
|
$508.59M |
|
$451.67M |
|
$508.59M |
|
58.21M |
|
| Cash Flow Statement Financials | |
$-171.06M |
|
$-240.29M |
|
$17.77M |
|
$605.74M |
|
$212.37M |
|
$-393.37M |
|
$81.55M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.92 |
|
-- |
|
-- |
|
-- |
|
-- |
|
72.39% |
|
-185.29% |
|
-185.29% |
|
-152.61% |
|
-184.30% |
|
-183.81% |
|
$-178.15M |
|
-- |
|
-- |
|
-- |
|
0.15 |
|
-- |
|
7.02 |
|
52.03 |
|
-61.50% |
|
-69.25% |
|
-27.93% |
|
-61.50% |
|
$8.74 |
|
$-3.21 |
|
$-3.08 |
|